Lippi G, Cadamuro J, von Meyer A, Simundic AM, on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56:718–27.CrossrefWeb of SciencePubMedGoogle Scholar
Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764–72.PubMedWeb of ScienceGoogle Scholar
Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306–7.Google Scholar
Aloisio E, Carnevale A, Pasqualetti S, Birindelli S, Dolci A, Panteghini M. Random uncertainty of photometric determination of hemolysis index on the Abbott Architect c16000 platform. Clin Biochem 2018;57:62–4.Web of ScienceCrossrefPubMedGoogle Scholar
Clinical and Laboratory Standards Institute [CLSI]. Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis: approved guideline. CLSI document C56-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.Google Scholar
Cadamuro J, Mrazek C, Haschke-Becher E, Sandberg S. To report or not to report: a proposal on how to deal with altered test results in hemolytic samples. Clin Chem Lab Med 2017;55:1109–11.Web of SciencePubMedCrossrefGoogle Scholar
About the article
Published Online: 2018-10-23
Published in Print: 2019-05-27
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.